E-4667 Erlotinib, Methanesulfonate Salt, >99%

Synonyms : [CP-358774] [OSI-774]

Related Terms : [Tarceva]

New
  • Size
  • US $
  • £
  • ¥
  • 500 mg
  • 37
  • 30
  • 27
  • 4,100
  • Add to Cart Qty:
  • In stock
  • 1 g
  • 48
  • 40
  • 35
  • 5,300
  • Add to Cart Qty:
  • In stock
  • 2 g
  • 72
  • 60
  • 52
  • 8,000
  • Add to Cart Qty:
  • In stock
  • 5 g
  • 136
  • 113
  • 100
  • 15,100
  • Add to Cart Qty:
  • In stock
  • 10 g
  • 238
  • 198
  • 175
  • 26,400
  • Add to Cart Qty:
  • In stock
  • 25 g
  • 490
  • 409
  • 360
  • 54,300
  • Add to Cart Qty:
  • In stock
  • 50 g
  • 870
  • 727
  • 640
  • 96,500
  • Add to Cart Qty:
  • In stock
  • 100 g
  • 1,560
  • 1,304
  • 1,148
  • 173,000
  • Add to Cart Qty:
  • In stock

Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.

To receive a Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities Click Here to see what Shipping and Handling Costs would be to Your Country
  • M.W. 489.54
  • C22H23N3O4•CH4SO3
  • [248594-19-6]

Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO.

Certificate of Analysis

  • This research compound is the methanesulfonate salt form of erlotinib; please see the other form of this product, Cat. No. E-4007, Erlotinib, Hydrochloride Salt, for further technical information about both of these research compounds. A third form of erlotinib, namely the free base is also available, Cat. No. E-4997, Erlotinib, Free Base.
  • This erlotinib product is the methanesulfonate salt, whose CAS number is given above. The CAS number of the Erlotinib, Hydrochloride Salt is 183319-69-9 and the CAS number of the Erlotinib, Free Base form is 183321-74-6.
  • Erlotinib (as the hydrochloride salt) is the active ingredient in the drug product sold under the trade name Tarceva®. This drug has been approved in at least one country for use in patients with pancreatic cancer, non-small cell lung cancer and several other types of cancer. NOTE: THE ERLOTINIB, FREE BASE, ERLOTINIB, METHANESULFONATE SALT, AND ERLOTINIB, HYDROCHLORIDE SALT RESEARCH COMPOUNDS, SOLD BY LC LABORATORIES ARE NOT TARCEVA®, AND ARE NOT FOR HUMAN USE.
  • Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use
  • This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
  • Not available in some countries; not available to some institutions; not available for some uses
1345